Posted by Michael Wonder on 20 Nov 2023
Teva announces approval of a generic version of Forteo (teriparatide injection) in the US
17 November 2023 - Forteo (teriparatide injection) is indicated to treat osteoporosis among certain women and men.
Teva Pharmaceuticals announced today the approval of a generic version of Forteo in the US. Market availability of the product in the US is expected in the coming weeks.
